| __timestamp | AbbVie Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 1488000000 |
| Thursday, January 1, 2015 | 4285000000 | 1525000000 |
| Friday, January 1, 2016 | 4366000000 | 2111000000 |
| Sunday, January 1, 2017 | 4982000000 | 1848000000 |
| Monday, January 1, 2018 | 10329000000 | 1213000000 |
| Tuesday, January 1, 2019 | 6407000000 | 1010000000 |
| Wednesday, January 1, 2020 | 6557000000 | 997000000 |
| Friday, January 1, 2021 | 7084000000 | 967000000 |
| Saturday, January 1, 2022 | 6510000000 | 838000000 |
| Sunday, January 1, 2023 | 8453000000 | 953000000 |
| Monday, January 1, 2024 | 12791000000 | 998000000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, AbbVie Inc. has consistently outpaced Teva Pharmaceutical Industries Limited in R&D investment. From 2014 to 2023, AbbVie's R&D expenses surged by approximately 156%, peaking in 2018 with a remarkable 10 billion dollars. In contrast, Teva's R&D spending has remained relatively stable, with a slight decline of around 36% over the same period. This strategic focus on R&D by AbbVie underscores its dedication to pioneering new treatments and maintaining a competitive edge. As the pharmaceutical industry continues to evolve, such investments are pivotal in driving future growth and addressing unmet medical needs. The data highlights the contrasting strategies of these two industry giants, offering insights into their long-term visions.
R&D Spending Showdown: AbbVie Inc. vs Alnylam Pharmaceuticals, Inc.
Analyzing R&D Budgets: AbbVie Inc. vs Madrigal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: AbbVie Inc. vs Rhythm Pharmaceuticals, Inc.
AbbVie Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: AbbVie Inc. and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Geron Corporation
Comparing Innovation Spending: Novartis AG and Teva Pharmaceutical Industries Limited
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Vericel Corporation
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated